These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19278069)

  • 1. [Mechanism for the efficacy of methylphenidate on attention deficit/hyperactivity disorder and related clinical evidence].
    Okada T
    Seishin Shinkeigaku Zasshi; 2008; 110(10):932-40. PubMed ID: 19278069
    [No Abstract]   [Full Text] [Related]  

  • 2. Pica in a child with attention deficit hyperactivity disorder and successful treatment with methylphenidate.
    Hergüner S; Hergüner AS
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1155-6. PubMed ID: 20547198
    [No Abstract]   [Full Text] [Related]  

  • 3. ADHD and addiction.
    Robbins TW
    Nat Med; 2002 Jan; 8(1):24-5. PubMed ID: 11786901
    [No Abstract]   [Full Text] [Related]  

  • 4. Doing Ritalin right. Sure, it works--but there are big flaws in the way it's being given.
    Brink S
    US News World Rep; 1998 Nov; 125(20):76-7, 80-1. PubMed ID: 10187350
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive variation in Ritalin prescribing.
    Gainsbury S
    Health Serv J; 2008 Jul; ():5. PubMed ID: 18705035
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylphenidate HCl: therapy for attention deficit hyperactivity disorder.
    Capp PK; Pearl PL; Conlon C
    Expert Rev Neurother; 2005 May; 5(3):325-31. PubMed ID: 15938665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More attention to ADHD.
    Sakakihara Y
    Dev Med Child Neurol; 2013 Apr; 55(4):296. PubMed ID: 23488944
    [No Abstract]   [Full Text] [Related]  

  • 9. [Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder: monitoring in biological matrices].
    Papaseit E; García-Algar O; Simó S; Pichini S; Farré M
    An Pediatr (Barc); 2013 Feb; 78(2):123.e1-10. PubMed ID: 23063334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An integrative approach of attention deficit in adolescence].
    Abadi AF
    Vertex; 2006; 17(70):458-64. PubMed ID: 17146504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of methylphenidate for attention deficit hyperactivity disorder.
    Kline CL
    CMAJ; 1990 Aug; 143(3):170-2. PubMed ID: 2073248
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of methylphenidate for attention deficit hyperactivity disorder.
    Brostë SM
    CMAJ; 1990 Nov; 143(10):995, 998. PubMed ID: 2073256
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features.
    Klorman R; Brumaghim JT; Salzman LF; Strauss J; Borgstedt AD; McBride MC; Loeb S
    Psychopharmacol Bull; 1989; 25(1):109-13. PubMed ID: 2772109
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug dependence and methylphenidate].
    Sora I; Ikari M; Ikeda K
    Seishin Shinkeigaku Zasshi; 2008; 110(10):941-5. PubMed ID: 19278070
    [No Abstract]   [Full Text] [Related]  

  • 15. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined treatment with moclobemide and methylphenidate for comorbid major depression and adult attention-deficit/hyperactivity disorder.
    Myronuk LD; Weiss M; Cotter L
    J Clin Psychopharmacol; 1996 Dec; 16(6):468-9. PubMed ID: 8959481
    [No Abstract]   [Full Text] [Related]  

  • 17. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An objective measure of methylphenidate response: clinical use of the MCA.
    Greenberg LM
    Psychopharmacol Bull; 1987; 23(2):279-82. PubMed ID: 3615775
    [No Abstract]   [Full Text] [Related]  

  • 19. Actigraphic evaluation for patients with attention deficit/hyperactivity disorder.
    Kawada T
    Am J Med Genet B Neuropsychiatr Genet; 2013 Apr; 162B(3):294. PubMed ID: 23460249
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.
    Jensen PS
    Am J Manag Care; 2009 May; 15(5 Suppl):S129-40. PubMed ID: 19601688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.